CSRO News

Displaying results 1-10 (of 49)
 |<  < 1 2 3 4 5  >  >| 

CSRO Policy Update, April 2017, Issue 5

In this issue: President’s Message; States Stride Toward Addressing; Patient Access Legislation; State Maps on Step Therapy & Biosimilars; Fellows Assemble in San Francisco to Prepare for Next Step; The Alliance for Transparent & Affordable Prescriptions; The Rebate System; ARA: CSRO Vice President Presents on PBMs and the Rebate System; CSRO discusses Biosimilars, Drug Pricing, and PBMs with CRA; CSRO Promotes Advocacy at 2017 CCR Conference; CSRO Participates in 2nd Annual National Policy & Advocacy Summit; Save the Date

READ MORE

ARA: CSRO Vice President Presents on PBMs and the Rebate System

The CSRO is pleased to report that CSRO Vice President Madeleine Feldman, MD, FACR, presented at the Arkansas Rheumatology Association, giving attendees an inside look at rising drug prices and the hidden rebate system controlled by pharmacy benefit managers (PBMs).

READ MORE

Formulary Changes Hurt the Patients Most

Rheumatologists are at the forefront of innovative treatments for patients with complex autoimmune diseases such as rheumatoid arthritis.

READ MORE

CSRO Submits Interchangeability Comments to FDA

As patient and physician advocates, we have been deeply involved in the debate surrounding implementation of the Biologics Price Competition and Innovation Act (BPCIA).

READ MORE

In the News: When Critical Medications Leave the Formulary, Patients Can Be Devastated

At the beginning of this new year, a worrisome change took effect for patients with chronic illnesses across Minnesota. Many patients have just become aware that their current medical treatment will no longer be covered, which may have a serious impact on their health in 2017 and lead to consequences beyond.

READ MORE

The CSRO Holds Another Successful Fellows Conference

On February 18, the CSRO held another successful Fellows Conference, complete with a host of interesting presentations on pertinent topics.

READ MORE

CSRO Policy Update, January 2017, Issue 4

In this issue: President’s Message; Biosimilar Advocacy Update; New CSRO Advocacy Initiative; Step Therapy Advocacy Update; Non-Medical Switching Legislation; Save the Date

READ MORE

CSRO Supports Step Therapy Legislation in Utah, Texas, and Iowa

This week was a big one for step therapy legislation, which moved forward in three key states.

READ MORE

CSRO Provides Testimony in Favor of Biological Products Legislation in Kansas

On Thursday January 26, CSRO Board of Director Dr. Mark Box made the case for biological products at the Kansas State Legislature’s Committee on Health and Human Services. House Bill 2107 would provide important pathways for safe access to biologic medications.

READ MORE

CSRO’s Continued Efforts to Address Step Therapy in 2017

State legislatures are now back in session and step therapy is once again at the forefront of our state policy initiatives as CSRO continues to support state legislation that seeks to regulate this practice.

READ MORE

Displaying results 1-10 (of 49)
 |<  < 1 2 3 4 5  >  >|